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Abstract
Background: Histamine is a biogenic amine that has been shown to contribute to several pathological conditions, such as
allergic conditions, experimental encephalomyelitis, and malaria. In humans, as well as in murine models of malaria,
increased plasma levels of histamine are associated with severity of infection. We reported recently that histamine plays a
critical role in the pathogenesis of experimental cerebral malaria (CM) in mice infected with Plasmodium berghei ANKA.
Histamine exerts its biological effects through four different receptors designated H1R, H2R, H3R, and H4R.
Principal Findings: In the present work, we explored the role of histamine signaling via the histamine H3 receptor (H3R) in
the pathogenesis of murine CM. We observed that the lack of H3R expression (H3R
2/2 mice) accelerates the onset of CM
and this was correlated with enhanced brain pathology and earlier and more pronounced loss of blood brain barrier
integrity than in wild type mice. Additionally tele-methylhistamine, the major histamine metabolite in the brain, that was
initially present at a higher level in the brain of H3R
2/2 mice was depleted more quickly post-infection in H3R
2/2 mice as
compared to wild-type counterparts.
Conclusions: Our data suggest that histamine regulation through the H3R in the brain suppresses the development of CM.
Thus modulating histamine signaling in the central nervous system, in combination with standard therapies, may represent
a novel strategy to reduce the risk of progression to cerebral malaria.
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Introduction
The main cellular reserves of histamine in peripheral tissues are
mast cells and basophils. Histamine release is involved in the
pathogenesis of various inflammatory reactions [1,2]. In the
central nervous system (CNS), histamine also acts as a neuro-
transmitter that is released by histaminergic neurons. The cell
bodies of histaminergic neurons are located exclusively in the
tuberomammillary nucleus of the posterior hypothalamus and
project their axons in a highly divergent manner to many cerebral
areas including the hypothalamus, thalamus, cerebral cortex,
amygdala, and septum [3,4,5,6]. Four histamine receptors have
been identified and termed H1-, H2-, H3-, and H4 receptors [3,7]
all of which are G-protein coupled receptors. The H1 receptor
(H1R) mediates most of the proinflammatory effects of histamine.
Anti-inflammatory and immunosuppressive effects of histamine,
such as inhibition of polymorphonuclear chemotaxis [8], and
interleukin (IL)-12 secretion by monocytes, and induction of IL-10
production [9], are mainly dependent on stimulation of the H2
receptor (H2R), which is positively coupled to the adenylyl cyclase
pathway. Unlike the other histamine receptors, H4 receptor (H4R)
is predominantly expressed on hematopoietic cells [10,11,12], and
H4R agonists were shown to induce chemotaxis of mast cells and
eosinophils [13] as well as the production of IL-16 by T cells [14].
Recently, using a murine model of allergic asthma, it was
demonstrated that H4R stimulation induces inhibition of airway
resistance and inflammation via a CD25
+FoxP3
+ T regulatory
cell-dependent mechanism [15].
In contrast to H1R, H2R, and H4R, H3R are mainly expressed
in neurons of the central and peripheral nervous system [16].
Presynaptic H3Rs located on histaminergic nerve endings, act as
autoreceptors to control the synthesis and release of histamine
[5,17]. Presynaptic H3Rs also act as heteroreceptors that influence
the release of other neurotransmitters including dopamine, c-
aminobutyric acid, noradrenaline, acetylcholine, serotonin and
tachykinins [18]. There is also some evidence for the existence of
H3R in the gastrointestinal tract where it exerts negative control
on gastric acid secretion [19]. Given the location of its expression,
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histaminergic tone, mediate various CNS functions affecting a
variety of behaviors. In this context, histamine was shown to play a
critical role in the regulation of the arousal state [20], locomotor
activity [21], food intake [22], memory and cognition [23].
With regard to neurological disorders, mice lacking H3R
(H3R
2/2) develop more severe experimental allergic encephalo-
myelitis (EAE) with a marked increase of blood brain barrier
permeability and an increased expression of macrophage-inflam-
matory protein (MIP)-2 and interferon-inducible protein-10 (IP-
10/CXCL10) on peripheral T cells. Furthermore, increased tissue
levels of histamine correlate with the onset of EAE [24,25,26].
Experimental cerebral malaria (CM) in mice is a severe
pathological condition resulting from infection with particular
strains of Plasmodium parasites, namely Plasmodium berghei ANKA
strain (Pb ANKA). Increased levels of histamine in plasma and
tissue is associated with the severity of human infection with P.
falciparum and in animal models of malaria [27]. In a recent study,
using pharmacological and genetic approaches, we demonstrated
that histamine plays a critical role in malaria pathogenesis in mice
[28]. We found that histamine signaling through H1R and H2R
increases the susceptibility of mice to infection with lethal strains of
P. berghei [28]. Furthermore, mice genetically deficient for the
histidine decarboxylase (HDC
2/2) gene, and thus lacking
histamine, were highly resistant to severe malaria whether infected
by mosquito bites or via injection of infected erythrocytes. To
investigate the role of H3R signaling in the regulation of the
inflammatory response in the brain during malaria, we studied Pb
ANKA-induced CM in H3R
2/2 mice. Herein, we report an
accelerated onset of cerebral malaria and increased blood brain
barrier (BBB) permeability in H3R
2/2 mice as compared to wild-
type mice.
Results
Lack of H3R expression accelerates the onset of CM
Wild type C57BL/6 mice display neurological signs character-
istic of CM within 6–11 days after infection with parasites from the
Pb ANKA strain, and death usually occurs within 24 h after the
onset of these signs [29]. Those mice that do not succumb during
this period will die later due to hyperparasitemia and anemia.
Based on previous data showing that the lack of histamine
production confers resistance to CM and given that H3R signaling
inhibits the synthesis and the release of histamine by histaminergic
neurons [5,17], we hypothesized that the uncontrolled histamine
release by histaminergic neurons, resulting from a deficiency in
H3R signaling, would be detrimental to the host during malaria
disease. To experimentally assess this hypothesis we studied the
role of the H3R in malaria pathogenesis, by monitoring the
parasitemia and death over time in H3R
2/2 mice inoculated with
10
6 infected erythrocytes. As shown in figure 1A, death occurred
significantly earlier (n=6, p=0.0092) in H3R
2/2 mice than in
similarly infected C57BL/6 control mice (median survival: day 6
and 9, respectively). A significantly higher parasitemia was
observed in H3R
2/2 mice at day 4 (p=0.0015) and day 5
(p=0.0124) post-infection (Fig 1B). Decreasing the infectious dose
of RBC to 10
5 per mouse did not alter the phenotypic difference
between the two mouse strains (data not shown), suggesting that
parasitemia does not represent the critical parameter for
accelerated disease expression and mortality in H3R
2/2 mice.
Among the critical signs observed during CM is the drop in body
temperature. In this regard, both H3R
2/2 and C57BL/6
displayed a decline in body temperature starting from day 5 and
no significant difference was observed between groups (Fig 1C).
Accelerated loss of BBB integrity in infected H3R
2/2 mice
The rapid onset of CM in H3R
2/2 mice prompted us to
determine whether or not the H3R signaling affects BBB
permeability during infection with Pb ANKA. We compared the
BBB permeability of C57BL/6 and H3R
2/2 mice at various time
points after inoculation with 10
6 infected erythrocytes. As shown
in figure 2B, the loss of BBB integrity occurred earlier at day 3 and
at a higher magnitude in H3R
2/2 mice than in C57BL/6 mice
(n=5, p=0.04) with almost no visible Evans blue dye extravasa-
tion in the brains from C57BL/6 mice (Fig. 2A). At day 6, the loss
of BBB integrity became more visible both in C57BL/6 and
H3R
2/2 mice (Fig. 2A) with a greater BBB permeability index in
H3R
2/2 mice (n=5, p=0.038) (Fig. 2B). The earlier loss of BBB
integrity in infected H3R
2/2 mice is consistent with the
accelerated onset of mortality (Fig. 1A).
The neurological signs that characterize CM are generally
accompanied by the sequestration of infected erythrocytes in the
cerebral vasculature [30,31]. Histological analysis of brain sections
obtained from naı ¨ve or at day 5 post-infection of C57BL/6 did
show very discrete erythrocyte aggregates observed in sections
from olfactory bulbs and other anatomical parts of the brain
(mouse 1, panel 4, Fig 3A). Deposition of erythrocyte aggregates,
representing either erythrocyte sequestration or cerebral hemor-
rhages, becomes more significant in C57BL/6 mice only by day 7
post-infection (data not shown, and [28]. In sharp contrast, higher
Figure 1. Role of H3R in Plasmodium berghei infection. H3R
2/2 and C57BL/6 mice were inoculated with 10
6 infected erthrocytes with Pb ANKA.
Kaplan-Meier Survival plots (A), parasitemia (B), and body temperature (C) were recorded. Significant differences in mortality/survival were observed
between C57BL/6 and H3R
2/2 mice using the log-rank test (n=6, p=0.0092). Differences in parasitemia between groups are significant at day 4 and
5 (Mann-whitney test, *** p=0.0015, and *p=0.0125, respectively), values represent mean6s.d. Data shown are representative of four independent
experiments.
doi:10.1371/journal.pone.0006004.g001
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identically infected H3R
2/2 mice (Fig 3A). Importantly, these
aggregates consisted of infected erythrocytes as shown by
fluorescence from GFP-expressing parasites used for infection
(Fig 3A). Quantification of brain lesions, expressed as the number
of erythrocyte aggregates in 100 consecutive microscopic fields
from each of the 3 histological sections made from the cerebellum,
confirmed a significantly larger number of infected erythrocyte
aggregates in H3R
2/2 mice as compared to C57BL/6 mice
(Fig. 3B). These data show that the loss of BBB integrity in infected
H3R
2/2 mice is associated with an accelerated formation of
hemorrhagic lesions and with earlier development of CM.
CM expression is associated with infiltrates of
inflammatory cells in the brain
To determine the number of adherent cells present in the brain,
nonadherent cells were removed by extensive perfusion of the
brain of anesthetized mice before sacrifice at various times after
infection with Pb ANKA. The perfused brains were removed and
the cells dissociated. Then the adherent leukocytes were isolated,
immunolabeled, and quantified by FACS. Given that recruitment
of CD4
+ and CD8
+ T cells in the brain is a hallmark of cerebral
malaria [28,29], a comparative analysis of CD4
+ and CD8
+ T cells
infiltrating the brain was performed in H3R
2/2 and C57BL/6
mice. The data were expressed as percentage of sequestered cells
(Fig. 4A) and as the absolute number of adherent cells (Fig. 4B).
We could observe a progressive sequestration of both CD4
+ and
CD8
+ T cells starting 3 days post-infection in both mouse strains.
At day 5, however, a higher sequestration of CD4
+ and CD8
+ T
cells was observed in H3R
2/2 mice as compared to C57BL/6
mice (p=0.04). FACS phenotyping, extended to other inflamma-
tory cell lineages, revealed an increase in the numbers of
macrophages/monocytes (CD11b
+-GR1 low) with a significantly
higher sequestration in H3R
2/2 mice that occurred relatively late
at day 5 post-infection (p=0.046). Analysis of CD11b
+-GR1 high
cells, likely representing neutrophils or inflammatory monocytes as
reported previously [32], also indicates a progressive increase
starting from day 3 post-infection with significantly higher levels in
H3R
2/2 mice as compared to C57BL/6 mice (p=0.04). More
detailed analysis of this cell population is described in supporting
figure 1.
tele-Methylhistamie contents in the brains of Pb ANKA-
infected mice
Once released from histaminergic neurons histamine is
metabolized by two major enzymes, histamine-N-methyl transfer-
ase (HMT) and monoamine oxidase B [5,17]. The HMT activity
gives rise to tele-methylhistamine (t-MeHA), an inactive metabolite
of histamine, the level of which accurately reflects neuronal
histamine activity [5,17]. To assess whether t-MeHA contents in
the brains are differentially modulated by the parasites in C57BL/
6 and H3R
2/2 mice, these mice were inoculated with 10
6 infected
erythrocytes and their brains harvested at various time points after
infection. As expected, given the regulatory role of H3
autoreceptors on histamine production, levels of t-MeHA in
uninfected mice were significantly higher in H3R
2/2 mice. At day
4 post-infection, there was a more dramatic decrease of the
amounts of t-MeHA in H3R
2/2 mice as compared to C57BL/6
mice (Fig. 5A). In H3R
2/2 mice, the decrease in t-MeHA contents
at all time points was significant as compared to the basal level.
Also, at all time points tested, the levels of t-MeHA were higher in
H3R
2/2 than in C57BL/6 mice. These findings suggest the
existence of either an infection-induced metabolism of histamine
after its release from its cerebral stores or an infection-induced
decrease of cerebral histamine synthesis.
To assess whether these changes in t-MeHA levels during
infection reflect a regulation at the level of the biosynthetic
pathway of histamine, we examined the level of expression of
histidine decarboxylase (HDC), the enzyme that converts histidine
into histamine. Kinetic analysis of HDC expression in the brain of
C57BL/6 and H3R
2/2 mice was performed at indicated times
after the initiation of the infection until the expression of clinical
signs of CM in H3R
2/2 mice. As shown in figure 5B, the basal
level of HDC mRNA was 3-fold higher in H3R
2/2 mice than in
C57BL/6 mice, a finding consistent with the higher level of t-
MeHA in the brains of naive H3R
2/2 mice (Fig. 5A). Until day 5
Figure 2. Accelerated loss of blood brain barrier in the brain of
H3R
2/2 mice. (A), Wild-type C57BL/6 mice and H3R
2/2 mice (3 mice
per group) were inoculated intraperitoneally with 10
6 infected
erythrocytes per mouse of Pb ANKA strain. At day 3 and day 6 post-
infection, mice were injected with a solution of Evans blue dye and 1 h
later were perfused with PBS and macroscopic observation of the brains
was made. Brains from uninfected mice were used as controls. (B)
Measurement of Evans blue dye extravasation by spectrophotometry.
Data are representative of two experiments. Significant differences were
determined by Mann-Whitney test.
doi:10.1371/journal.pone.0006004.g002
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2/2
mice but at day 6, there was a marked decrease in the level of
HDC expression. The regulation of the HDC expression was
different in C57BL/6 mice where the HDC gene was significantly
upregulated and was maintained at a constant level through day 6.
It is striking to observe that, except for naive mice where the
amounts of brain t-MeHA were well correlated with levels of HDC
gene expression, in infected mice this correlation was poor in both
mouse strains. This indicates that additional regulatory mecha-
nisms associated with histamine metabolism are brought into play.
In an attempt to evaluate the impact of Plasmodium infection on
serum histamine levels, we compared histamineamia of H3R
2/2
mice and C57BL/6 mice infected or not with Pb ANKA. As shown
in figure 5C, higher levels of histaminaemia were observed in
infected H3R
2/2 mice as compared to C57BL/6 mice only at day
3 and 5 (p=0.0117) post-infection. This suggests an association
between higher plasmatic levels of histamine and the severity of
the disease in H3R
2/2 mice, a parallel previously observed in
murine models of CM [28] and in human infection [33]. These
data also show that histamine levels are differentially regulated in
peripheral compartments as compared to the brain.
Splenic cytokine production during Pb ANKA infection
To explore the immune response of peripheral tissues during Pb
ANKA infection, IL-10, IFN-c, and TNF-a produced in vitro by Pb
ANKA stimulated splenocytes from infected H3R
2/2 and
C57BL/6 mice were measured at various time points after
infection. As shown in Fig. 6, all three cytokines could be elicited;
IL-10 and TNF-a production peaked with a delay of one day in
H3R
2/2 mice as compared to C57BL/6 mice. Kinetically, the
pattern of IFN-c looks similar in the two mouse strains with
however a 3-fold higher production (p,0.01) in H3R
2/2 mice. At
day 5, splenocytes from both mouse strains showed an inability to
produce IL-10 and IFN-c and a drastic reduction of TNF-a
production upon antigenic challenge which at this time was
maintained in H3R
2/2 mice (Fig. 6). Since cytokines were
induced in an antigen-dependent manner and no cytokines could
be detected in antigen-stimulated unprimed splenocytes, cytokines
were presumably produced by antigen-specific T cells. This
pattern of time-dependent cytokine production, parallel to
previous findings [34], was consistent with cell proliferation as
measured with thymidine uptake (data not shown). These data
indicate that the divergent susceptibility to CM of H3R
2/2 and
C57BL/6 mice could be a result of likely differences in T cell
cytokine responses and thus supports a role for locally and
peripherally dysregulated inflammatory response.
A protective role for H3R agonists and H1R, and H2R
inhibitors in CM
The higher susceptibility of H3R
2/2 mice to CM suggests that
histamine regulation via H3R has a protective effect in CM. To
further assess the function of H3R during malaria disease,
C57BL/6 mice were treated with (R)-alpha-methylhistamine, a
standard H3R agonist [5,17], and infected with Pb ANKA
parasites. As shown in Figure 7A, administration of (R)-alpha-
Methylhistamine had a significant protective effect with a median
survival time of 24 days as compared with a median survival time
of 15.5 days for untreated mice (n=8, p=0.029). Since we
previously found that histamine signaling via H1R and H2R has a
profound impact in malaria disease [28], and to verify that H1R
and H2R inhibitors have additional beneficial effects to the
naturally protective function of H3R, we examined the effect of
Levocetirizine (H1R inhibitor) and cimetidine (H2R inhibitor) on
CM in C57BL/6 mice. Administration of Cimetidine prolonged
Figure 3. Formation of hemorrhagic lesions occurs earlier in the brain of H3R
2/2 mice. Wild-type C57BL/6 mice and H3R
2/2 mice (3 mice
per group) were inoculated intraperitoneally with 10
6 Pb ANKA-infected erythrocytes per mouse. At day 5 post-infection, mice were perfused with
PBS then PFA 4% and brain sections were made. (A) Brains Sections stained with May-Gru ¨nwald Giemsa. Blood-stage parasites associated with
sequestered erythrocytes (panels 10, 11, and 12) in the brain could be visualized by fluorescence (panels, 7, 8, and 9) because of their expression of
GFP only in H3R
2/2 mice (white shadow indicated by arrows). At this time, no deposition of fluorescent parasites could be observed in brain sections
from uninfected (not shown) and only scarce number of aggregates could be detected in infected C57BL/6 mice (arrow in panel 4 for mouse 1). Data
are representative of three mice per group. (B), The density of erythrocyte aggregates in brain sections of infected H3R
2/2 and C57BL/6 mice were
expressed as the average of aggregates in three sections and counted in 250 consecutive microscopic fields per section at magnification 2506. These
data are from two different experiments. *** Significant difference was obtained between infected H3R
2/2 and C57BL/6 mice using Mann-Whitney
test (p=0.0003). Bar, 100 mm.
doi:10.1371/journal.pone.0006004.g003
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mice as compared to a survival time of 15.5 days for untreated
ones (n=8, p=0.03) (Figure 7B). Preventive treatment with
Levocetirizine had a more protective effect against CM since
median survival time was more than 25 days for treated mice as
compared to a survival time of 8 days for untreated ones
(Figure 7C). These data on median survival time demonstrate the
shift from death by CM to mortality associated with hyperpar-
asitemia mediated by pharmacologically decreasing histamine
activity.
To further examine the efficacy of the preventive therapeutic
effect of H1R and H2R inhibitors in the absence of the naturally
protective H3R, H3R
2/2 mice were treated with Levocetirizine
and Cimetidine and inoculated with Pb ANKA parasite-infected
erythrocytes. As shown in figure 7D, Cimetidine significantly
prolonged the survival time (p=0.015) whereas Levocetirizine was
less effective (p=0.08) (Figure 7E). Altogether, these data suggest
that mimicking (H3R) or antagonizing (H1R and H2R) the
biological effects of histamine may improve disease outcome in
malaria infection. The fact that no difference in parasitemia
between treated and untreated groups was observed suggests that
the pharmacologic effects of histamine receptor inhibitors are
exerted on host response rather than directly on the parasite.
To look whether histamine receptor inhibitors are able to
protect mice once the infection is established, C57BL/6 mice were
infected with Pb ANKA parasite-infected erythrocytes and
beginning 5 days post infection mice were treated every day with
either Levocetirizine or Cimetidine. As shown in figure 8A and C,
Levocetirizine but not Cimetidine significantly increased mouse
survival (p=0.025, and p.0.05, respectively). Again, treatment
with either drug appears to not effect parasite development
directly since parasitemia in all treated groups was similar to that
of control untreated mice (Figure 8B and D). Additional
experiments where mice were treated using histamine H1 and
H2 receptor inhibitors at the time of neurological sign manifes-
tations did not show any therapeutic effect (supporting figure 2).
We subsequently examined whether histamine effector func-
tions via H1R and H2R alters expression of inflammatory genes in
the brain in the context of functional (C57BL/6) or non functional
H3R (H3R
2/2). Analysis of mRNA expression of TNF-a and
IFN-c, two cytokines typically associated with CM, was performed
by RT-PCR in the brain from C57BL/6 and H3R
2/2 mice
Figure 4. Characterization of brain infiltrating cells during infection with Pb ANKA parasites. At indicated time points post-infection,
brains from C57BL/6 and H3R
2/2 mice infected with 10
6 infected erythrocytes per mouse of Pb ANKA strain were taken and leukocytes associated
with cerebral tissue were analyzed for the presence of CD4
+ and CD8
+ T cells and other inflammatory cells. Data are expressed as a percentage of
total cell population (A) and absolute cell numbers per brain (B). Six mice per group were used. Values represent the mean6standard deviation of
two experiments. (B) Differences between C57BL/6 and H3R
2/2 mice are significant at day 5 for total CD4
+ and CD8
+ T cells (Mann-Whitney test,
*p=0.04). Differences in total neutrophils/inflammatory monocytes (CD11b
+ GR1 High cells) and (CD11b
+ GR1 Low cells) between C57BL/6 and
H3R
2/2 mice are significant at day 5 (Mann-Whitney test, *p=0.04, and p=0.046, respectively).
doi:10.1371/journal.pone.0006004.g004
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or not with 10
6 Pb ANKA-infected erythrocytes. As shown in
figure 9, a significant decrease of TNF-a (p=0.0005, and 0.0002)
and IFN-c (p=0.0022, and 0.0028) mRNA expression was
observed in C57BL/6 mice treated with Levocetirizine, and with
Cimetidine, respectively. In H3R
2/2, mRNA expression of TNF-
a was significantly reduced (p=0.03, and p=0.009) following
treatment with Levocetirizine and Cimetidine, respectively
whereas a significant down-regulation of IFN-c gene expression
was obtained only in mice treated with Cimetidine (p=0.042).
These data demonstrate that the therapeutic effect of H1R and
H2R inhibitors appears to be more effective in the situation where
H3R is functional (wild-type C57BL/6 mice) and can be
interpreted at least in part by dampening the expression of
inflammatory response-associated genes known to be critical for
disease expression during CM.
Discussion
It is widely recognized that the production of proinflammatory
mediators and cytokines as well as the upregulation of endothelial
cell adhesion molecules play an important role in the development
Figure 5. Regulation of histamine metabolism upon infection
with Pb ANKA. (A) C57BL/6 and H3R
2/2 mice were sacrificed at
indicated time points after receiving blood stage parasites of Pb ANKA
inoculated intravenously, and brain extracts were prepared for t-MeHA
measurements. Differences in t-MeHA level between groups are
significant (Mann-Whitney test, n=5, *** p,0.001, ** 0.001,p,0.01,
and * 0.01,p,0.05). In C57Bl/6 mice, significant differences in t-MeHA
level appeared day 5 post-inoculation (Kruskal Wallis test, p=0.0061
followed by Dunn’s Multiple Comparaison test, *** p,0.0001). In H3R
KO mice, significant differences in t-MeHA level appeared day 4 post
inoculation (Kruskal Wallis test, p=0.008 followed by Dunn’s Multiple
Comparaison test, *** p=0.0002). The t-MeHA level for H3R
2/2 mice on
day 7 is absent due to the high level of mortality by that time point. (B)
Transcription of the HDC gene in the brain (n=6/group) at different
time points post-infection as evaluated by real-time RT-PCR. mRNA
expression was normalized relative to hypoxanthinephophoribosyl-
transferase expression for each mouse strain. * indicates that
differences are significant (Mann-Whitney test, 0.01,p,0.05) relative
to the basal level in C57BL/6 mice (grey bars), and ** indicates that
these values are significantly different (Mann-Whitney test,
0.001,p,0.01) relative to the t-MeHA level measured at day 6 in
H3R
2/2 mice (black bars). *** indicates that HDC mRNA from H3R
2/2
mice are significantly down-regulated as compared to that of C57BL/6
mice at day 6 (Mann-Whitney test, * p=0.0336). (C) Determination of
plasmatic histamine levels; histamineamia was measured by ELISA in
naı ¨ve and infected C57BL/6 and H3R
2/2 mice at different time points
after inoculation with 10
6 blood stage parasites of Pb ANKA. Values
represent mean6standard deviation from three experiments. *A
significant difference in histamineamia post infection between H3R
2/2
mice and C57BL/6 mice were observed at day 3, and day 5 (Mann-
Whitney test, p=0.0117) only.
doi:10.1371/journal.pone.0006004.g005
Figure 6. Antigen-specific T cell responses and cytokine
analysis. Spleen cell preparations from infected H3R
2/2 and C57BL/6
mice were seeded at 2610
6 cells/ml and incubated for 72 h in the
presence or absence of 30 mg/ml of Pb ANKA lysate. After incubation,
the supernantants were harvested and tested for their content in IL-10,
TNF-a, and IFN-c and measured by ELISA. * indicates that differences
are significant (Mann-Whitney test, p=0.039). Each experiment is
representative of three distinct infections.
doi:10.1371/journal.pone.0006004.g006
Disrupted H3R & Malaria Severity
PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e6004and progression of cerebral pathology in malaria disease [35]. It
has been hypothesized that CM is precipitated by the disruption of
the brain microvasculature that results from the uncontrolled
inflammatory reaction associated with inappropriate immune
response [35]. During malaria pathogenesis, it is difficult to
establish which comes first, the breakdown of BBB integrity or the
pathogenic inflammatory response. We propose that resistance to
CM development relies in the ability to control the inflammatory
response that otherwise mediates immunopathological processes.
Our recent research was been based on the hypothesis that
histamine is one of the earliest and potent inflammatory mediators
that affects the host immune response to Plasmodium parasites.
Recently, we tested this hypothesis by investigating the role of
histamine in the occurrence of CM [28]. We found that HDC
2/2
mice that lack histamine are resistant to the induction of CM
during infection with Pb ANKA. In this mouse model, we found
that the absence of histamine prevents leukocyte adhesion and
sequestration of infected erythrocytes to the brain vasculature, and
Figure 7. Effect of preventive treatment with histamine receptor agonists and antagonists on the occurrence of cerebral malaria.
Wild-type C57BL/6 and H3R
2/2 mice were left untreated (diamonds) or treated (squares) with a H3R agonist R-a-MeHA or either the H1R or H2R
inhibitors, respectively, Levocetirizine, and Cimetidine, before and during infection with 10
6 infected erythrocytes per mouse. These data are from
two independent experiments. Significant differences in mortality/survival (A, B, C, D, E) were observed between drug-treated and untreated mice
using the log-rank test. No significant differences in parasitemia between treated and untreated groups (F, G, H, I, J) were observed.
doi:10.1371/journal.pone.0006004.g007
Figure 8. Effect of treatment with histamine receptor inhibitors on ongoing Pb ANKA infection. Panels A and C indicate survival rates of
C57BL/6 infected with Pb ANKA 5 days prior daily treatments until the end of the experiment with either Cimetidine or Levocetirizine. These data are
from one experiment using 7 mice per group. Significant differences in mortality/survival were observed between drug-treated and untreated mice
using the log-rank test. Parasitemia (B, and D) were not significant.
doi:10.1371/journal.pone.0006004.g008
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cells [28]. Given the predominant expression in the central
nervous system of the H3R, one of the four identified histamine
receptors, the possibility exists that signaling through this
particular histamine receptor may control the development of
Plasmodium-associated brain pathology. We investigated the role of
H3R in the onset of CM, using mice with non-functional H3R
gene. We observed a significantly earlier emergence of clinical
signs of CM with more rapid death in H3R
2/2 mice as compared
to identically infected wild type C57BL/6 mice. Although higher
parasitemia was observed at day 4 and 5 in H3R
2/2 mice as
compared to wild-type mice, it is unlikely that a causative
relationship exists between parasitemia levels and pathology.
Indeed, high parasitemia levels could be elicited in histamine-
deficient HDC
2/2 mice [28] and RAG
2/2 mice (personal
observation) without any disease expression. The accelerated
death of H3R
2/2 mice is associated with an earlier and more
pronounced loss of BBB integrity than in infected C57BL/6 mice
(Fig 2). These findings are consistent with an uncontrolled
histamine release by histaminergic neurons in H3R
2/2 mice.
Indeed, histamine release by these neurons is tightly regulated by
H3R, which act as inhibitory autoreceptors for the synthesis and
release of histamine [5,17] and as H3 heteroreceptors to inhibit
the release of other neurotransmitters including dopamine, c-
aminobutyric acid, noradrenaline, acetylcholine, and serotonin in
the CNS [18]. Estimating neuronal histamine levels in the brain,
by measuring the histamine metabolite t-MeHA as an index,
confirmed that neuronal histamine activity is significantly higher in
naive H3R
2/2 mice than in C57BL/6 mice. However, following
infection, tele-methylhistamine levels in the brain dropped sharply
below constitutive levels in H3R
2/2 mice while in C57BL/6 mice
this decrease was not obvious. This observation is consistent with a
tighter control exerted by the H3R on histamine release from
neuronal cells in C57BL/6 mice, which is absent in H3R
2/2
mice. This decrease could be due either to a down-regulation of
the HDC gene expression or an up-regulation of the HMT
expression in response to the infection. We found that the
catabolism pathway was not affected since the expression of HMT,
which converts histamine into the biologically inactive compound
tele-methylhistamine, was not altered throughout the infection
period (data not shown). In naı ¨ve mice the biosynthetic pathway as
determined by HDC mRNA expression indicates that expression
in the brain was 3-fold higher in H3R
2/2 mice than in C57BL/6
mice, a finding consistent with the control of histamine synthesis
by H3 autoreceptors [5,17]. After infection with Pb ANKA, the
regulation of HDC mRNA expression showed distinct patterns in
H3R
2/2 and in C57BL/6 mice. It appears that while the
expression of HDC increased in both mouse genotypes, at day 6
post-infection a down-regulation occurred only in H3R
2/2 mice.
A possible explanation for the earlier loss of BBB integrity in
H3R
2/2 mice consists of a surge in histamine available in the
brain. This histamine likely binds to H1R and H2R which may
then alter the permeability of brain capillaries resulting in the loss
of BBB integrity. Our data show that the expression of clinical
signs is associated with decreases in tele-methylhistamine levels, and
HDC mRNA expression in the brain. However, it remains unclear
by which mechanism these decreases occur in an accelerated
manner in infected H3R
2/2 mice. Because histamine neuron
activity is involved in the regulation of body temperature [5] the
earlier down-regulations observed in H3R
2/2 mice might result as
an effect of hypothermia [36,37] known to occur during CM and
just prior death. As part of the established neuroprotective effect of
hypothermia, it was also reported very recently that hypothermia
induced increased concentrations in the brain of galanin, a
neuropeptide known to be co-localized with histamine in rodent
histaminergic neurons and to modulate their activity [38]. Hence,
an up-regulation of the neuropeptide galanin could provide a
possible explanation [39,40,41]. Nonetheless, we could not detect
differences in either the expression of galanin or in the drop of
body temperature between H3R
2/2 and C57BL/6 mice (data not
shown). Given the complexity of the physiological regulations of a
vast array of neurotransmitters by histamine via H3R signaling
[38], future studies will explore if and how these neurotransmitters
are modulated during Plasmodium infection in wild-type mice and
in H3R
2/2 mice.
In CM pathogenesis, it has been well established that a major
effector is CD4
+ and CD8
+ T cells which sequester within cerebral
blood vessels [42] along with parasitized red blood cells. Previous
studies indicated that association of activated CD4
+ and CD8
+ T
cells [42,43,44] and other inflammatory cells with the endothelial
cells of brain vasculature is a characteristic of experimental CM.
We examined whether the higher susceptibility of H3R
2/2 mice
was reflected by a differential recruitment of these cells as
compared to wild type C57BL/C mice. Analysis of brain-
associated CD4
+ and CD8
+ T cells after infection with Pb ANKA
parasites displayed a constant rise in T cells with similar kinetics in
both genotypes until day 5 where a higher number of cells was
detected in the brains from H3R
2/2 mice. Considering the fact
that other inflammatory cells such as neutrophils [45,46] and
monocytes [47] contribute to CM pathogenesis, we evaluated and
observed, as for T cells, a sequestration of a higher number of cells
in the brains of infected H3R
2/2 mice. Furthermore, T cell
sequestration was dominated by CD8
+ T cells. Looking at a
possible difference in terms of peripheral T cell response, the
splenocytes from the mouse strains, challenged ex-vivo with Pb
ANKA lysate, produced variable amounts of IL-10, IFN-c and
Figure 9. Down-regulation of inflammatory response-associat-
ed genes by histamine receptor antagonists. Wild-type C57BL/6
and H3R
2/2 mice were treated or not with H1R inhibitor (Levocetirizine)
or H2R inhibitor (Cimetidine) one day before and throughout the
infection period by inoculating 10
6 Pb ANKA-infected erythrocytes. Six
days post-infection, brains were analyzed for the expression of TNF-a
and IFN-c as measured by quantitative RT-PCR. Gene mRNA expression
is normalized relative to hypoxanthinephophoribosyltransferase. Data
are presented as the means6SD from two independent experiments.
Significant differences between groups indicated by presence of a bar
over the respective columns were determined by Kruskal-Wallis test
followed by Dunn’s Multiple Comparison test.
doi:10.1371/journal.pone.0006004.g009
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ultimately ending with an immunosuppression at day 5 post-
infection occurring in both mouse strains. This immune
suppression is consistent with earlier data [34], further suggesting
that inhibition of the T cell proliferation and cytokine production
was under the control of CD4
+CD25
+ T regulatory cells elicited
during Pb ANKA infection. One exception for this immune
suppression is TNF-a whose production by splenocytes from
H3R
2/2 mice was less affected. The sustained TNF2a
production by splenocytes combined with a sequestration of a
higher number of CD4
+ and CD8
+ T cells and increased
production of pro-inflammatory cytokines in the brain may
account for the more severe disease developed by H3R
2/2 mice.
A critical and consistent difference between the two mouse
genotypes is the earlier disruption of the BBB and the concomitant
hemorrhagic lesions in H3R
2/2 mice at day 3 post-infection, a
time when no clinical sign had manifested.
Histamine is implicated in the pathophysiology of multiple
sclerosis and its animal models, collectively termed EAE [48]. Our
findings are in agreement with a recently published report on EAE
showing that, compared with wild-type animals, H3R
2/2 mice
develop a more severe disease and neuroinflammation along with
dysregulated BBB permeability [48]. Typically, the increased
clinical disease observed during the early phase of EAE in H3R
2/
2 mice was associated with earlier and more severe inflammatory
infiltrates. Also, the degree of the BBB permeability was
significantly higher in H3R
2/2 compared with C57BL/6 mice.
As for EAE, two opposite, although not exclusive hypotheses, may
account for the pathogenetic mechanisms involved in the disease
expression during experimental CM. The immune-based hypoth-
esis which contends that parasite-specific CD4
+ and CD8
+ T cells
exert their effector functions within brain capillaries, and the
alternative hypothesis that emphasizes the brain tissue-initiated
inflammatory response, which represents the primary pathological
event leading to disease progression. Disruption of H3R reveals
that during Pb ANKA infection, the ability of this receptor to
normalize histamine release within the brain tissue is important for
limiting immunopathology and supporting a positive outcome.
Subsequent to the brain-initiated inflammatory events (Fig. 2, and
3), CD4
+ and CD8
+ T cells and inflammatory cells adhere to brain
capillaries leading to their detrimental effect. In this regard, we
propose a similar chronological pattern of pathogenetic events as
in EAE and as discussed by Teuscher et al. [48].
Uncontrolled histamine release in various immunopathological
conditions where the brain tissue represents the site of pathoge-
netic events may support the utility of pharmacological targeting of
H3R via receptor agonists to prevent the development of tissue
lesions either in multiple sclerosis or during CM. Our data support
this pharmacological approach since the use of (R)-alpha-
methylhistamine, a standard H3R agonist [5,17], was demon-
strated to be effective in reducing progression to CM. Although,
such class of drug is not available yet for a therapeutic use in
humans, our work provides a rational basis for a future use of H3R
agonists, alone or in combination with H1R or H2R inhibitors, as
they become available. The single use, however, of an H1R
inhibitor Levocetirizine or an H2R inhibitor Cimetidine when
H3R is functional appears to be promising since both drugs were
effective in preventing the development of clinical signs and
mortality due to CM. This therapeutic effect was translated at the
molecular level at least in part by the down-regulation of
inflammatory response-associated genes such as IFN-c and
TNF-a. Hence, the beneficial role of H3R in limiting disease
expression by controlling histamine release and metabolism is
highlighted by the higher therapeutic effectiveness and better
control of inflammatory gene expression exerted by H1R and
H2R inhibitors when H3R is functional. The compensatory
protective effect provided by Cimetidine and to a lesser extent by
Levocetirizine in H3R
2/2 mice suggest that expression of a
functional H3R constitutes a minimal condition that helps slow the
development of severe disease. Once the infection was established,
we found that only Levocetirizine significantly increased survival
to CM. Furtheremore, Levocetirizine appeared to be more
efficient when delivered as a preventive treatment than when it
was administered therapeutically. This argues for a preferential use
of H1R and H2R inhibitors as a preventive therapy. This would
be more feasible in areas where malaria transmission is seasonal.
In the absence of any impact or alteration of parasite development,
our data are not consistent with previous findings showing that
Astemizole, an H1R inhibitor, directly interferes with Plasmodium
parasite metabolism, thus altering its development [49]. Our
previous and current data with histamine support a mechanism by
which anti-histamines administered during infection with Pb
ANKA affect the host immune response by maintaining the
inflammatory response at levels that are less detrimental to the
host and thereby reducing progression to CM.
Materials and Methods
Ethics statement
All animal care and experimentation were conducted in accord
with Pasteur Institute animal care and use committee guidelines.
Mice
Female C57BL/6 mice 6–8 wk old were purchased from
Charles River Breeding Laboratories (Saint-Aubin les Elbeufs,
France). H3R
2/2 mice [50] were provided by Dr Robin L.
Thurmond (Johnson & Johnson Pharmaceutical Research and
Development, San Diego, California). All knockout mice origi-
nated from the C57BL/6 background.
Parasites and infection
For all infections, a cloned line of Plasmodium berghei ANKA (Pb
ANKA) strain stably transfected with the green fluorescent protein
(GFP) on hsp70 promoter [51], was utilized allowing the detection
of sporozoites and blood stage parasites by fluorescent microscopy.
Pb ANKA was provided by Dr. T. Ishino (Department of Medical
Zoology, Mie University School of Medicine, Edobashi, Tsu,
Japan). Infection of mice induces experimental CM, characterized
by paralysis, ataxia, convulsions and coma between 6–11 days
post-infection. This parasite was maintained in a cycle between
C57BL/6 mice and An. stephensi [52]. The erythrocytic stages of
the parasite were maintained in liquid nitrogen as parasitized red
blood cells in Alsever’s solution (Sigma, France) containing 10%
glycerol. The infection was induced by intraperitoneal injection of
10
6 parasitized red blood cells.
Preparation of brain cell suspensions
The brains were obtained from H3R
2/2 mice at the coma stage
of CM and at the same time from wild-type C57BL/6 mice (day
6). Briefly, mice were anesthesized with ketamine (600 mg/kg) and
xylazine (20 mg/kg) and perfused with 30 ml of PBS via the left
ventricle of the heart to remove circulating and nonadherent RBC
and leukocytes from the brain vasculature. Brain-associated
leukocytes were obtained as described previously [28].
Flow cytometric analysis of brain leukocytes
Brain cells were stained for FACS analysis according to
standard protocols in cold PBS containing 2% FCS and 0.01%
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Biosciences, Le Pont de Claix, France): FITC-labeled anti CD45,
APC-labeled CD4, phycoerythrin (PE)-labeled anti-CD8a, PE-
labeled anti-GR1, and APC-labeled anti-CD11b. After staining
with Abs, cells were washed then resuspended in FACS buffer
before flow cytometric analysis. A total of 5610
4 living cells for
brain, gated as CD45-positive cells, were analyzed using a four-
color FACSCalibur flow cytometer with ProCellQuest software
(BD Biosciences, Mountain View, California).
Permeability of the blood-brain barrier
When mice infected with Pb ANKA strain began showing
neurological symptoms, usually at day 6–7 post-infection. A
volume of 200 mL of 2% (w/v) solution of Evans Blue in PBS was
injected into the mice retro-orbitally. One hour later, mice were
perfused with PBS after anesthesia with ketamine (600 mg/kg) and
xylazine (20 mg/kg). Each brain was removed and photographed.
Animal perfusion and histological analysis
To analyze only brain-associated leukocytes, mouse perfusion
consisted of intracardiac injection of 100 ml PBS, followed by
200 ml of 4% paraformaldehyde in PBS. The brains were fixed for
3 days in 1% paraformaldehyde solutions and then were
subsequently cryoprotected in a 30% sucrose phosphate-buffered
solution at 4uC for 3 days before cutting. For May-Gru ¨nwald
Giemsa staining procedure, the protocols used to obtain brain
sections (40 mm thick) were described elsewhere [53,28]. Although
sequestration of infected erythrocytes occurs evenly without any
particular localization in the brain tissue (infected erythrocytes
were found in olfactory bulbs, cortex, thalamus, hypothalamus,
and cerebellum), sections were made in three different mice from
the same anatomical sites of the cerebellum only. Detection of
blood-stage parasites associated with sequestered erythrocytes in
the brain could be visualized either by May-Gru ¨nwald Giemsa
staining or GFP fluorescence. The density of erythrocyte
aggregates in brain sections of infected and control mice were
expressed as the average of aggregates per field and counted in 100
consecutive microscopic fields from 3 histological sections per
brain at magnification 2506. Images of randomly selected were
collected using an Olympus upright microscope (BX61) (Center
Valley, Pennsylvania) equipped with an oil-immersion lens (606)
and a cooled video camera (Qimaging, Retiga 2000R, Burnaby,
Canada) with a color conversion filter. Digitizing was performed
with a PC computer using the image analysis system Image-Pro
Plus (MediaCybernetics, Silver Spring, USA).
Splenocyte proliferation assay and cytokine production
Spleen cells from C57BL/6 or H3R
2/2 mice were collected at
different time points after infection with Pb ANKA and incubated
for 72 h in the presence or absence of 30 mg/ml of Pb ANKA
lysate. For proliferation assays, 200 ml total splenocyte suspensions,
diluted in complete RPMI 1640 medium–5% fetal calf serum,
were seeded in 96-well plates at a density of 2610
6 cells/ml. Cells
cultured in medium alone were used as background controls.
[methyl-
3H]thymidine (2 mCi/well; Amersham Biosciences, Unit-
ed Kingdom) was added 16 h before harvesting, and radioactivity
was measured using a Betaplate counter. For cytokine detection,
the cell culture supernatants were collected and analyzed for their
cytokine content by capture enzyme-linked immunosorbent assay
(ELISA). Detection of IL-10, IFN-c, and TNF-a was performed
according to the manufacturer’s instructions (BD Biosciences,
Mountain View, California).
Quantification of brain-associated HDC, HMT, and
immune signaling molecules
Gene expression in the brains from H3R
2/2 and C57BL/6
mice at various time points post-infection was analyzed by the real-
time RT-PCR. RNA utilized for these assays was isolated by
means of a two-step extraction process. First, brains were
surgically removed from mice as previously described and placed
immediately in RNAlater at 4uC overnight. After RNAlater
infused the samples, it was removed and samples were maintained
at 280uC until processing. Brains were thawed in 1 ml of Trizol
and subjected to bead disruption in a polytron 3 times from 2 min
at a setting of 30 cycles/sec. Samples were spun at high speed
(10,0006g) for 3 min to remove debris and lipids. Half of the
sample was transferred to a new tube and mixed with 500 mlo f
Trizol reagent by vortexing. Following this step, RNA extraction
proceeded according to manufacturers protocol. Precipitated
RNA was resuspended in 100 ml of RNase-free water. The second
step of this extraction was followed by Qiagen’s protocol for RNA
clean-up including steps for removal of protein and DNA (Qiagen
RNeasy Kit). Samples were eluted with 50 ml of RNase-free water
and quality and quantity assured by photospectroscopy. Real-time
RT-PCR utilized various primer-probe sets and standard Taqman
protocols (Applied Biosystems) [54].
Determination of tele-Methylhistamine Levels in brain
After infection, animals were sacrificed and the brain was
homogenized in 10 volumes (w/v) of ice-cold perchloric acid
(0.4 N). t-MeHA levels in the supernatants were determined using
an enzymoimmunoassay derived from a radioimmunoassay
described previously [55]. Briefly, t-MeHA of the sample was
derived with p-benzoquinone (BZQ) (2.8 mg/ml). The reaction
was allowed to proceed at pH 7.9 for 3 h, then 2 M glycine was
added to eliminate the excess of p-benzoquinone. The extract was
mixed with t-MeHA-p-benzoquinone-Leu-Tyr-acetylcholinester-
ase as a tracer and an antiserum raised in rabbits against t-MeHA
conjugated with bovine serum albumin via p-benzoquinone in a
96-well plate (Nunc Immuno-Plate Maxi-Sorp Surface; Nunc,
Roskilde, Denmark) pretreated with swine anti-rabbit IgG
(Cayman Chemical, Ann Arbor, MI). After incubation for 16 h
at 15uC, plates were washed and the substrate for acetylcholin-
esterase, Ellmann’s reagent, was added. After 5 h, the optical
density was measured with a Dynatech Mr 5000 at 405 nm. The
limit of the detection was 5 pg of t-MeHA.
Treatments
The histamine receptor subclass-specific inhibitors Cimetidine
(H2R), and Levocetirizine (H1R) and the H3R agonist (R)-alpha-
methylhistamine (R-a-MeHA) were injected i.p. daily at 10 mg/kg
until the end of the experiment, starting 24 h before infection. To
test the therapeutic effect on histamine receptor inhibitors, in one
experiment, Cimetidine and Levocetirizine were injected daily
from day 5 post-infection until the end of the experiment.
Levocetirizine was kindly obtained from UCB Biopharma
(Brussels, Belgium), whereas Cimetidine and R-a-MeHA were
purchased from Sigma (St Louis MO). Histamineamia was
determined using ELISA kits purchased from Neogen Corporation
(Lexington, KY).
Statistical analysis
Significant differences in survival were evaluated by generation
of Kaplan-Meier plots and log rank analysis. p,0.05 was
considered statistically significant. For other analyses, when
differences between C57Bl/6 and H3R-KO mice were compared
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significance set at p,0.05. When comparing differences between
days after inoculation within each strain of mice, we performed the
Kruskal-Wallis test followed by an a posteriori Dunn’s multiple
comparison test.
Supporting Information
Figure S1 Morphological characterization of the CD11b+GR1
high cell population. This cell population could represent a
population of GR1+ inflammatory monocytes that are elicited
during Plasmodium parasite infection. We have reassessed cellular
analysis using anti-GR1 Ab combined with the 7/4 mAb (Caltag
Laboratories) which reacts with the 7/4 antigen that is a
polymorphic 40 kD molecule expressed by polymorphonuclear
cells, but absent on resident tissue macrophages. This analysis is
shown in S1A. A similar pattern was obtained as previous
experiments based on high expression of GR-1 epitope. However,
the 7/4 antigen can also be expressed by inflammatory monocytes
as shown in S1D with a key difference in that inflammatory
monocytes express less GR1 and 7/4 antigen than neutrophils. We
further examined these cells which were sorted using a cell-sorter
(5 days post-infection) as shown in annex 1B (purity 96% based on
GR1High/7/4 expression) and which morphologically resemble
activated neutrophils as observed by electron microscopy (S1C).
These cells were also shown to release myeloperoxydase upon
phorbol myristate acetate stimulation.
Found at: doi:10.1371/journal.pone.0006004.s001 (1.10 MB TIF)
Figure S2 Treatments with histamine receptors inhibitors have
no therapeutic effect when administered at the time of CM
neurological symptoms. C57BL/6 mice were first infected with
106 parasitized erythrocytes and when the mice showed signs of
cerebral malaria at day 7 (60 to 80% of the mice), they received
daily either Levocetirizine or Cimetidine.
Found at: doi:10.1371/journal.pone.0006004.s002 (0.25 MB TIF)
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